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Abstract 
Objectives: The purpose of this study was to evaluate and compare the cytotoxic effects of ProRoot MTA and 
DiaRoot BA, a bioceramic nanoparticulate cement, on subcutaneous rat tissue. 
Study Design: Fifty Sprouge Dawley rats were used in this study. Polyethylene tubes filled with ProRoot MTA and 
DiaRoot BioAggregate, along with a control group of empty, were implanted into dorsal connective tissue of rats for 7, 
15, 30, 60, and 90 days. After estimated time intervals the rats were sacrificed. The specimens were fixed, stained with 
hematoxylin and eosin, and then evaluated under a light microscope for inflammatory reactions and mineralization. 
Results: All groups evoked a severe to moderate chronic inflammatory reaction at 7 and 15 days, which decreased 
with time. Both the MTA and BioAggregate groups showed similar inflammatory reactions, except at 90 days when 
MTA showed statistically significant greater inflammation (p>0.05). The MTA group showed foreign body reaction 
at all times. Compared to BioAggregate, MTA showed significantly more foreign body reaction at 60 and 90 days 
(p<0.0001). After 30 days foreign body reaction of BioAggregate decreased significantly. Both MTA and BioAggre-
gate groups showed similar necrosis at 7 and 15 days (p=0.094 and p=0.186 respectively). No necrosis was observed 
after 15 days. Similarly there was no fibrosis after 30 days for both MTA and BioAggregate groups (p>0.05). 
Conclusions: Since DiaRoot BioAggregate showed significantly better results than MTA, we can conclude that it 
is more biocompatible. However, further studies are required to confirm this result.
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Introduction
Mineral trioxide aggregate (MTA) is the most frequent-
ly and preferentially used material in dental practice for 
sealing the communication between root canal system 
and periodontium. It is composed of tricalcium and di-
calcium silicate, tricalcium aluminate, calcium sulfate 
(gypsum) (1), and a 4-to-1 addition of bismuth oxide 
for radiopacity. It is marketed as MTA ProRoot MTA 
(Dentsply, Tulsa Dental Products, Tulsa, OK) (2). Be-
cause of its remarkable biological and physical proper-
ties it is widely used in dental practice in contact with 
both soft and hard tissues as a root-end filling and api-
cal barrier material, root canal perforation repair agent, 
pulp capping material, intraorifice barrier, and paste 
for root canal obturation material (3,4). MTA is very 
similar to Portland cement (1). Due to the materials used 
to manufacture Portland cement, it may contain some 
heavy metals including arsenic, chromium, and lead 
with amounts varying between 5 and 100 parts per mil-
lion (ppm). Because of its similarity to Portland cement, 
there is some concern that MTA could also release haz-
ardous substances (5). There is a lack of information 
about how MTA is manufactured. The manufacturer 
claims that the production is performed under isolated 
and clean conditions to eliminate the risk of contami-
nation. The materials used to manufacture MTA are 
certified for being pure and free of heavy metal con-
tamination (2). Despite their similarities, there are two 
very important differences between MTA and Portland 
cement. First, bismuth oxide is only found in MTA. Sec-
ond, MTA has a lower tricalcium aluminate level. This 
implies that the two materials are not manufactured in 
the same way (5).
DiaRoot Bio-Aggregate (BA) (Innovative BioCaramix 
Inc, Vancouver, BC, Canada) is a new water-based ce-
ment. Like MTA, it is used for retrograde filling and root 
canal perforation repair. The composition of BA is tri-
calcium silicate, dicalcium silicate, tantalum pentoxide, 
and calcium phosphate monobasic. To provide radio-
pacity, tantalum pentoxide is used in BA rather than the 
bismuth oxide used in MTA. The manufacturer claims 
that DiaRoot is produced under controlled conditions to 
form contamination-free biocompatible ceramic nano-
particles (DiaRoot; DiaDent, Burnaby, BC, Canada). It 
is the first nanoparticulate repair cement introduced on 
the dental market. It is claimed that BA promotes ce-
mentogenesis and forms a hermetic seal; however, stud-
ies do not support this claim (3,6).
MTA and BA have similar compositions and uses. The 
most significant difference between these two products 
is that BA is aluminum-free. This is important because 
irritation caused by toxic effects of such endodontic re-
pair materials, which come into contact with both soft 
and hard tissues, may be responsible for degeneration 
of the periapical tissue and/or delayed wound healing 
(7). Because both cements were previously classified as 
“permanent-contact implant devices” (3,8), in vitro bio-
compatibility tests (cytotoxicity, tissue implantation as-
says, etc.) are required before advising wide range clini-
cal use. Various studies have concluded that MTA can 
induce the regeneration of periodontal ligaments (9,10). 
Osteoblasts also displayed a favorable response to MTA. 
Studies have also found the apposition of a cementum-
like material and formation of bone (9,10). MTA con-
sistently offered a biologically active substrate by stim-
ulating interleukin production (3,11). 
Under these circumstances it is very favorable for BA 
to be compared with MTA for its biocompatibility and 
cytotoxicity cause as mentioned before they are very 
similar in many ways but developed to serve as a bet-
ter choice. The purpose of this study was to evaluate 
and compare the cytotoxic effect of bioaggregate and 
mineral trioxide aggregate on subcutaneous connective 
tissue of rats.
Material and Methods
This study was revised and approved by the Istanbul 
University Local Committee on Animal Research Eth-
ics. Fifty male Sprouge Dawley rats weighing 250-300 
g were used in this study. All ethical criteria in care 
and use of laboratory animals were observed according 
to the Istanbul University Local Committee on Animal 
Research Laboratory (Vote number 10/2009). In this 
study the animals were divided into 3 groups: 
Group 1: In this group ProRoot MTA (Dentsply, Tulsa 
Dental Products, Tulsa, OK) was used.
Group 2: In this group DiaRoot BA (DiaDent, Burnaby, 
BC, Canada) was used.
Group 3: Control group
All 3 groups were divided into 5 subgroups (n=10 rats) 
according to estimated time intervals of 7, 15, 30, 60, and 
90 days. Both MTA and BA were prepared according to 
the manufacturers’ directions, and they were immedi-
ately placed in sterile polyethylene tubes with 1.0-mm 
internal diameter, 1.5 mm external diameter, and 10-
mm length. Animals were anesthetized with 25 mg/kg 
of ketamine plus 10 mg/kg of xylazine, and their backs 
were shaved and disinfected with 10% Batikon (Kim-Pa, 
Istanbul, Turkey). Three 3-mm incisions with a number 
15 blade (Aesculap, Tuttlingen, Germany) were made 
at least 3 cm apart on the back of each rat in a head-to-
tail direction. The test materials were implanted into 2 
separate incisions. The third received an empty tube as 
a control in each rat. The incisions were closed with a 
3/0 silk suture. After 7, 15, 30, 60, and 90 days, the rats 
were sacrificed in an induction chamber by using a high 
dose of ketamine (Bayer Turk, Istanbul, Turkey). The 
tubes and surrounding tissues were excised in a 2-2 cm² 
dimension and fixed in 10% buffered formalin (Merck, 
Darmstadt, Germany) for 2 weeks. Sections of 5-µm 
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thickness were made perpendicular and as near as pos-
sible to the opening of tubes and stained with hematox-
ylin and eosin to evaluate inflammatory reactions (12)
and mineralized structures (dystrophic calcification) in 
the tissue. Microscopic evaluations were made through 
a light microscope (Carl Zeiss, Oberkachen, Germany) 
at 100 and 400 magnifications. 
Evaluations of inflammatory cells were made in five 
separate areas (13). 
The inflammatory reactions were scored as follows: 
Grade 0: Zero or few inflammatory cells and no reac-
tion,
Grade 1: Fewer than 25 inflammatory cells and mild 
reaction,
Grade 2: Between 25 and 125 inflammatory cells and 
moderate reaction,
Grade 3: 125 or more inflammatory cells and severe re-
action (13).
Evaluation of fibrous capsules was scored in 2 groups:
1. thin (less than 150 mm),
2. thick (more than 150 mm) (13).
The quantity of dystrophic calcification was scored as 
follows:
3: more than two thirds of the tube periphery.
2: between one third and two thirds of the tube periphery.
1: less than one third of the tube periphery.
0: when no calcification existed (14).
In our histological evaluation we also included the 
presence of necrosis and foreign body reactions in the 
soft tissue around the implanted materials. Presence of 
necrosis was scored as follows:
1. Present
2. Not present
Foreign body reactions were scored as follows:
1. Present
2. Not present
Histological sections were evaluated by 2 independent 
operators who were blinded to the materials and time 
periods. 
-Statistical analysis
Statistical calculations were performed with NCSS 
(Number Cruncher Statistical Systems) 2007 statistical 
software (Utah, USA) program for Windows. In addition 
to the standard descriptive statistical calculations (frequen-
cy, percent), chi-squared test and Fisher’s exact test were 
performed for the evaluation of the quantitative data. Sta-
tistical significance level was established at p<0.05.
Results 
-Inflammatory reactions
In all groups a severe to moderate chronic inflammatory 
reaction was observed at 7 and 15 days, which decreased 
with time. Both the MTA and BA groups showed se-
vere inflammatory reactions compared to the control 
group at 7 (p=0.005, p=0.023) and 15 days (p=0.002, 
p=0.001), but there was no statistically significant dif-
ference between the MTA and BA groups (p=0.999, 
p=0.639). The presence of an inflammatory reaction 
in the MTA group was significantly greater than in the 
control group at 60 and 90 days (p=0.032, p=0.0001). 
The BA group, by contrast, did not show any significant 
difference (p=0.303, p=0.087). The inflammatory reac-
tion difference for both the MTA and BA groups was 
statistically significant at 7, 15, and 30 days. After 30 
days a moderate to mild reaction was observed. At 60 
days no statistically significant difference was observed 
between the MTA and BA groups, whereas at 90 days 
the MTA group showed a significantly greater reaction 
than the BA group (p>0.05) (Table 1, Fig. 1).
-Evaluation of fibrous capsules
For all groups at all time intervals, the distribution of 
fibrous capsule (FC) presence was not statistically sig-
nificant (p>0.05). In the MTA group the presence of 
FC at 7 days was significantly greater than at 30, 60, 
and 90 days (p=0.003, p=0.0001). At 15 days the pres-
ence of the capsules was greater than at 60 and 90 days 
(p=0.003). More FC were observed in the BA group at 
7 days than at 60 and 90 days (p=0.02, p=0.0001). The 
observed FC at 15 and 30 days were greater than at 90 
days (p=0.0007, p=0.011) (Table 2, Fig. 2).
The quantity of dystrophic calcification
At all time intervals for the BA and control groups, 
there were no dystrophic calcifications (DC) present. In 
the MTA group at all time intervals there were statisti-
cally significant differences in the distributions of DC 
(p=0.064) (Fig. 3).
-Presence of necrosis
No necrosis was observed in any group at 30, 60, and 
90 days. In the MTA group, necrosis was significantly 
greater at 7 days than at 15, 30, 60, and 90 days (p=0.003, 
p=0.0001). The BA group also showed statistically signifi-
cant results at 7 days only (p=0.005, p=0.0001) (Fig. 4).
-Foreign body reactions
At 7 and 15 days foreign body (FB) reaction was observed 
in all groups. With similar distributions at 30 days, the 
7. Day 15. Day 30. Day 60. Day 90. Day 
MTA Group / DIA Group 0,999 0,639 0,656 0,210 0,011 
MTA Group / Control Group 0,005 0,002 0,057 0,032 0,0001 
DIA Group  / Control Group 0,023 0,001 0,303 0,650 0,087 
Table 1. Comparison of inflammatory reactions of groups at each evaluation period.
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MTA and BA groups presented significantly a greater 
FB reaction than the control group (p=0.003). At 60 and 
90 days the MTA group showed a greater FB reaction 
than the BA and control groups, which was statistically 
significant (p=0.0001). In MTA group FB reaction was 
observed for all specimens at all days (Table 3).
Discussion 
Materials used in endodontics are frequently placed in 
close contact with the periodontium and thus must be 
nontoxic and biocompatible with the neighboring tis-
sues. Bioactivity refers to the ability of a biomaterial 
to produce a chemical bond with vital tissues through a 
 7. Day 15. Day 30. Day 60. Day 90. Day 
MTA Group / DIA Group 0,999 0,999 0,370 0,210 - 
MTA Group / Control Group 0,210 0,999 0,999 0,210 - 
DIA / Group Control Group  0,582 0,628 0,656 - - 
Table 2. Comparison of fibrous capsules presence at each evaluation period.
Fig. 1. Inflammatory reactions of the tested materials at each evaluation periods (%).
Fig. 2. Fibrous capsules presence of the tested materials (%).
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Fig. 3.  Dystrophic calcification of groups at each evaluation period (%).
Fig. 4. Necrosis presence of the tested materials at each evaluation period (%). 
F.B. Reac. MTAGroup 
DIA 
Group 
Control
Group p
7.Day Present 10 100,00% 10 100,00% 10 100,00%  
15.Day
Not
Present 0 0,00% 0 0,00% 3 30,00% 0,096 
Present 10 100,00% 10 100,00% 7 70,00% 
30.Day
Not
Present 0 0,00% 0 0,00% 7 70,00% 0,0001 
Present 10 100,00% 10 100,00% 3 30,00% 
60.Day
Not
Present 0 0,00% 10 100,00% 10 100,00% 0,0001 
Present 10 100,00% 0 0,00% 0 0,00% 
90.Day
Not
Present 0 0,00% 10 100,00% 10 100,00% 0,0001 
Present 10 100,00% 0 0,00% 0 0,00% 
p 0,0001 0,0001 
Table 3. Foreign body reactions (F.B Reac.) of groups at each evaluation period.
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compliant interface (15). There are few data about BA’s 
biocompatibility. Therefore, the present study was de-
signed to assess and compare the cytotoxic effects of 
MTA and BA (3). 
The biocompatibility and induction characteristics of 
MTA are not completely understood and are likely mul-
tifactorial (16,17). Bioactivity is thought to be the reason 
behind the biocompatibility and mineralization induc-
tion capacity of MTA (17). Sarkar et al. (18) suggested 
that calcium ions released by MTA produce superficial 
and interfacial hydroxyapatite (HAp) precipitate in con-
tact with dentin in the presence of phosphate-buffered 
saline (PBS). It is characterized as B-type carbonated 
apatite (19). Known as biologic apatite, carbonated apa-
tite represents the mineral phase of hard tissue, which is 
more similar to bone apatite than pure Hap (16,20).
There are several in vitro and in vivo tests to evaluate 
the biocompatibility of dental materials. These include 
testing the general toxicity profile of potential materi-
als in a cell culture, implantation tests, and usage tests 
in experimental animals according to accepted clinical 
protocols. A number of biocompatibility and mutagenic-
ity studies have shown that MTA is a biocompatible ma-
terial (4,21). The results of a meta-analysis of MTA bio-
compatibility showed that MTA is more biocompatible 
than Super EBA, IRM, and silver amalgam (22).
Many studies have compared the subcutaneous reaction 
of MTA to other materials such as amalgam, CH, Super 
EBA, various root canal sealers, IRM, ZOE, cold ce-
ramic, and ethoxybenzoic acid (EBA) on experimental 
animals (4,12). One study compared the subcutaneous 
reactions of AMTA and Endo CPM sealer to Sealapex. 
Results showed that for a brief interval (7 days), both 
types of MTA caused mild to moderate reactions that 
decreased with time (23). Results on Day 30 were simi-
lar to the control, and at Day 60 results were similar to 
Sealapex. No significant difference was seen between 
the two types of MTA. Mineralization and granulations 
were observed for all the materials (23). Results of the 
present study echoed those of previous studies (12, 23) 
in that there were similar reactions caused by MTA. 
At 7 and 15 days both BA and MTA caused severe to 
moderate inflammation which decreased with time. But 
the reactions caused by MTA decreased significantly 
slower than BA. Another study investigating the effects 
of Endo-CPM-Sealer (EGEO SRL, Buenos Aires, Ar-
gentina), Sealapex (Sybron Endo, Glendora, CA), and 
Angelus MTA (Angelus, Londrina, Brazil) on cell vi-
ability and cytokine (interleukin [IL]-1beta and IL-6) 
production by mouse fibroblasts concluded that none of 
the materials was considered cytotoxic in fibroblast cul-
ture. Endo-CPM-Sealer, Sealapex, and Angelus MTA 
did not inhibit the cell viability. Angelus MTA induced 
IL-1beta releasing significantly more than did the con-
trol (24). Ma et al. (25) evaluated the biocompatibility of 
2 root-end filling materials, Endosequence Root Repair 
Material Putty (ERRM Putty) and Paste (ERRM Paste), 
and compared them to gray mineral trioxide aggregate 
(MTA). In this study, ERRM Putty and ERRM Paste 
displayed similar in vitro biocompatibility to MTA.
These studies showed that subcutaneous responses to 
MTA range from necrosis to dystrophic calcification. 
In addition, at first, MTA produces a moderate to se-
vere subcutaneous response, which subsides at longer 
time intervals (4). Consistently with these findings, in 
the present study, MTA showed similar subcutaneous 
responses which decreased with time. 
With technological characteristics and composition sim-
ilar to white MTA, differing mostly in that it is alumi-
num-free, BA is the first nanoparticulate repair cement 
introduced to the dental market. It allegedly promotes 
cementogenesis and forms a hermetic seal inside the 
root canal system, but few published studies indicate its 
effectiveness (3,6). In a study of extracted human max-
illary incisors, the researchers compared the cytotoxic 
effects of MTA and BA as a root-end filling material. No 
statistically significant differences between MTA and 
BioAggregate were found in the experimental periods. 
DiaRoot BioAggregate displayed in vitro compatibility 
similar to MTA (3). Contrary to this study results, in the 
present study BA showed statistically significantly bet-
ter results than MTA for biocompatibility. This could 
be due to  laboratory animals (Sprouge Dawley rats) 
were used in the present study instead of in vitro test, 
thus in this study model BA demonstrated statistically 
significant biocompatibility compared to MTA. Yuan 
et al. (26) investigated the cytotoxicity of BA and the 
effect of BA on mineral-associated gene expression in 
osteoblast cells, which is in contrast with our results. 
In our study, we found that MTA induced dystrophic 
calcification, where BA failed to show any dystrophic 
calcification. They suggested that BA appears to be a 
novel nontoxic root-end filling biomaterial and is able 
to induce mineralization-associated gene expression in 
osteoblast cells. In a study of iRoot SP root canal filling 
material, AH Plus and MTA were evaluated for their 
biocompatibility with L929 mouse fibroblasts. It was 
concluded that AH Plus root canal sealer was signifi-
cantly more toxic to L-929 cells than MTA and iRoot 
SP. iRoot SP had intermediate toxicity (27). Mukhtar-
Fayyad (28) evaluated and compared the cytotoxicity of 
2 bioceramic-based materials, BioAggregate and iRoot, 
on human fibroblast MRC-5 cells. The researcher found 
that both BioAggregate and iRoot SP displayed an ac-
ceptable biocompatibility. Also, the cytotoxic effect of 
both materials was concentration-dependant.
Conclusions
Based on the results of this study, we can conclude that 
both BA and MTA are biocompatible materials. How-
Med Oral Patol Oral Cir Bucal. 2013 Jul 1;18 (4):e745-51.                                                                                                                       Cytotoxicity of mineral trioxide aggregate and bioaggregate
e751
ever, the BA group showed significantly better inflam-
matory and foreign body reaction than the MTA group. 
Therefore we suggest that BA is more biocompatible 
than MTA. However, MTA showed better results at 
presence of dystrophic calcification compared to BA. 
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